The world’s leading private supporter of novel research in lupus harnesses the power of innovation to drive scientific progress in this complex disease.
Early clinical trials suggest the investigational drug blisibimod may be safe and effective in treating lupus.
As reported by Lupus Daily News, a new study published in International Journal of Molecular Sciences shows that a standard lupus treatment can affect osteoporosis.
A new study finds that Benlysta, approved for lupus, may benefit patients with Sjögren’s.
As reported by Rheumatology Network, a new study published in American Journal of Public Health reports that unfair treatment by healthcare professionals is associated with disease damage among black women.
A new study suggests a target for developing a potential lupus treatment.
Learnings from two epratuzumab studies will inform progress in this complex autoimmune disease
Key DiscoveriesLupus Clinical Trials
Text to GiveDonate for Discovery
Local Lupus Events